Avai Bio, Inc.
AVAI • Software - Application
$0.12
▲ +0.00 (+2.68%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$16.05M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.03Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Mar 31, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:35 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.12
Change2.68%
Shares Out139.56M
Market Cap$16.05M
Enterprise Value$17.82M
52W Range0.11 - 0.80
Beta0.87
P/E-9.17
P/B-5.70
P/FCF-15.89
EV/EBITDA-11.71
EV/FCF-17.65
Price$0.12
Change2.68%
Shares Out139.56M
Market Cap$16.05M
Enterprise Value$17.82M
52W Range0.11 - 0.80
Beta0.87
P/E-9.17
P/B-5.70
P/FCF-15.89
EV/EBITDA-11.71
EV/FCF-17.65
Earnings Yield-10.90%
FCF Yield-6.29%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.64
Current Ratio0.03
Quick Ratio0.03
Volume14.99K
Avg Volume157.61K
Investment DNA
How strong this company looks for long-term investors
27
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Weak liquidity · 0.03Negative growth trendWeak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.